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The  generation,  migration,  and  differentiation  of  neurons  requires  the  functional  integrity  of  the  micro-
tubule  cytoskeleton.  Mutations  in  the  tubulin  gene  family  are  known  to cause  various  neurological
diseases  including  lissencephaly,  ocular  motor  disorders,  polymicrogyria  and  amyotrophic  lateral  scle-
rosis. We  have  previously  reported  that  mutations  in  TUBB5  cause  microcephaly  that  is accompanied  by
severe intellectual  impairment  and  motor  delay.  Here  we present  the  characterization  of a  Tubb5  mouse
model  that allows  for the  conditional  expression  of  the  pathogenic  E401K  mutation.  Homozygous  knockin
animals  exhibit  a severe  reduction  in  brain  size  and  in  body  weight.  These  animals  do  not  show  any  sig-ubulinopathies
icrocephaly
alformations of cortical development
otor defects
repulse inhibition
niﬁcant  impairment  in  general  activity,  anxiety,  or  in  the  acoustic  startle  response,  however,  present  with
notable defects  in  motor  coordination.  When  assessed  on the static  rod apparatus  mice  took  longer  to
orient  and  often  lost  their  balance  completely.  Interestingly,  mutant  animals  also  showed  defects  in pre-
pulse  inhibition,  a phenotype  associated  with  sensorimotor  gating  and  considered  an  endophenotype  for
schizophrenia.  This  study  provides  insight  into  the behavioral  consequences  of  tubulin  gene  mutations.
© 2017  The  Authors.  Published  by  Elsevier  B.V.  This  is  an  open  access  article  under the  CC  BY-NC-ND. Introduction
The mammalian neocortex is the result of sequential devel-
pmental processes that encompass the generation, migration,
nd differentiation of neurons [1,2]. Microtubules are known to
lay a crucial role in each of these cellular events. During mitosis
icrotubules mediate the separation of sister chromatids; during
euronal migration they form a cage around the nucleus facilitat-
ng its movement; and during differentiation microtubules support
he extension of axonal and dendritic processes [3]. The importance
f the microtubule cytoskeleton in neurodevelopment is reﬂected
y the discovery that mutations in various tubulin genes result
n a spectrum of neurological diseases, including: lissencephaly;
olymicrogyria; ocular motor disorders, and amyotrophic lateral
clerosis [4–15]. In humans the tubulin gene family consists of 8
lpha- and 9 beta-isoforms [12]. We  have previously reported that
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mutations in TUBB5 cause microcephaly with structural brain phe-
notypes [8,16]. Tubb5 is expressed at high levels in both progenitors
and post-mitotic neurons throughout embryonic development,
which is maintained at moderate levels postnatally and in adult-
hood. Patients with mutations in TUBB5 present primarily with
neurological symptoms including: a reduction in orbitofrontal cor-
tex, dysmorphic basal ganglia, dysplasia of the cerebellar vermis,
agenesis of the corpus callosum, ataxia, severe language delay, and
intellectual impairment.
We have generated a conditional Tubb5 knockin mouse model
that allows for the replacement of the endogenous allele with the
pathogenic E401K mutation in a tissue speciﬁc manner [17]. This
mouse line phenocopies the reduction in brain size observed in
patients, which is associated with the perturbation of cell cycle
progression in neuronal progenitors and the induction of p53-
dependent apoptosis. Traditionally, mouse models associated with
neurodevelopmental disease are subject to detailed characteriza-
tion of the defective developmental events in utero that result in
anatomical perturbations in the mature nervous system [18–21].
Frequently, however, the impact of any given mutation on the
behavioral repertoire of the animal is overlooked. In our view,
this is a glaring oversight, as these models may  assist in under-
standing patient phenotypes and, potentially, provide a measurable
parameter that could be used for therapeutic screens. This is par-
ticularly important in light of the growing evidence that severe
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.
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eurodevelopmental disorders can be alleviated with therapeutic
nterventions postnatally [22–25]
Accordingly, we have undertaken a systematic behavioral
ssessment of our E401K Tubb5 mouse mutant complementing our
revious work on this gene [4,8,16,17]. Our battery of tests reveals
hat homozygous E401K animals have motor coordination defects,
irroring the human phenotype accompanied by an impairment
n prepulse inhibition indicative of defects in sensorimotor gating.
. Materials and methods
.1. Animal housing and breeding
Mice were maintained on a 12:12 light:dark cycle at a tempera-
ure of 22 ± 1 ◦C with a humidity of 60–70%. Males and females were
ept separately with a maximum of ﬁve male or six female mice in
ach cage. Animals had ad libitum access to food and water. Exper-
ments were performed in accordance with the Austrian Animal
xperiments Act (TVG) and Genetic Engineering Act (GTG) under
he license number GZ: 11600/2015/25. Tubb5ﬂE401K/ﬂE401K mice
ere generated and bred as described before [17].
.2. MRI
Preparation of mice and generation of MRI  images were done
s described before [17]. In short, mice were transcardially per-
used with 0.9% NaCl and 4% PFA containing 10% ProHance Solution
Bracco Imaging Group, 4002750). Whole heads were than imaged
ith a 15.2 T Biospec horizontal bore scanner (Bruker BioSpin,
ttlingen, Germany).
.3. Behavioral testing
All behavioral experiments were performed on sex-matched lit-
ermates (n = 7 females and 7 males; total n = 14). Each mouse was
ubjected to one test per day and littermates were tested on the
ame day. Tests were performed in the same order for each ani-
al  (one test a day), starting at 8 weeks of age. The order of the
ests were as follows: open ﬁeld, elevated plus maze, accelerating
otarod, multiple static rods and the acoustic startle response with
repulse inhibition. The same person conducted all experiments at
he same time of the day. Behavioral setups were cleaned with 70%
thanol between tests to avoid extraneous odors.
.3.1. Open ﬁeld
The open ﬁeld test was  performed in an enclosed grey PVC
rena (40 cm x 40 cm base; 30 cm height). Following placement
f a mouse in the corner of the arena while facing the wall, its
ovement and position were tracked for 5 min  using the Anymaze
oftware (Stoelting Co., Wood Dale, IL, USA) [26].
.3.2. Elevated plus maze
The elevated plus maze consisted of two opposing open arms
29 cm long, 6 cm wide) and two opposing enclosed arms (27 cm
ong, 6 cm wide, 18 cm height) placed 30 cm above the ground. Fol-
owing placement of the mouse in the middle facing one of the
losed arms its movement and position was tracked for 5 min  using
he Anymaze software (Stoelting Co., Wood Dale, IL, USA).
.3.3. Accelerating rotarod
Mice were placed on the beam of the rotarod (Ugo Basile, Italy)acing in the opposite direction relative to the rotation for 1 min  at
 rpm. Subsequently, the rod automatically accelerated to a maxi-
um  of 30 rpm over 4 min. The latency before falling was measured
p to a maximum of 6 min. Three trials with 1 h intervals weren Research 323 (2017) 47–55
carried out [27]. Animals had not previously been exposed to the
rotarod.
2.3.4. Acoustic startle response with prepulse inhibition
The commercially available setup (San Diego Instruments, San
Diego, CA, USA) consists of a mouse chamber mounted on an
accelerometer inside a soundproof box with a 6 cm speaker that
delivers the acoustic stimuli. Following placement inside the cham-
ber, the mouse was allowed to acclimatize 5 min. The acoustic
stimuli were delivered at four different intensities (90, 100, 110
and 120 dB) as 40 ms  of white noise for a total of 20 times [28].
Subsequent prepulse inhibition testing was performed at two dif-
ferent pre pulses (90 dB and 95 dB) followed by the same 120 dB
stimulus. Averaged response from 0 to 120 was  used as maximum
value. All stimuli were delivered in a pseudorandom order at ran-
dom intervals ranging from 10 to 20 s. Responses were assembled
in arbitrary units and averaged for each startle intensity.
2.3.5. Multiple static rods
The multiple static rods setup consisted of a series of ﬁve
60 cm long wooden rods with decreasing width (rod 1:3.3 cm; rod
2:2.7 cm;  rod 3:2.1 cm;  rod 4:1.4 cm;  and rod 5:0.8 cm)  mounted
perpendicularly to the supporting base that was elevated 60 cm
above a cushioned surface [26]. Starting with rod 1, mice were
placed on the distal end facing away from the supporting base. Both,
latency to turn 180 ◦ to face the base (orientation time) and the total
time until all four paws were placed on the supporting base (time
to target) were recorded for a maximum of 180 s. If the mouse fell
from one of the rods or turned upside down during the test it was
given the maximum score of 180 s [26]. After each individual rod
tested mice were returned to the cage to rest.
2.4. Statistical methods and data analysis
Brain weights were compared between genotypes using a one-
way ANOVA, with a post-hoc Tukey comparison. For the static
rod test, prepulse inhibition test, and rotarod experiments we
performed repeated measures ANOVAs using the trial rounds for
each mouse as the repeated factor and genotypes as the between
subject factor, we also tested for an interaction effect between
genotypes and trial round. The open ﬁeld experiments and the ele-
vated plus maze were analyzed using one-way ANOVA models in
order to test for differences between the three genotypes. For all
tests a Tukey post-hoc comparison was  used to compare genotypes
within the ANOVA models, and to assess trial improvement for the
rotarod experiments. Where multiple measures were obtained in
one experiment, we  corrected for multiple testing using a Bonfer-
roni correction. An assessment of sex was initially performed on all
datasets, however, we observed no sex effect with the exception
of the acoustic startle response (see Table S2 in the online version
at DOI: http://dx.doi.org/10.1016/j.bbr.2017.01.029). The acoustic
startle response was  therefore analyzed using a two-way ANOVA
model including sex and genotype for each of the DB levels followed
by a Bonferroni correction. All analyses were calculated using Prism
7 for Mac  OS X (Version 7.0a).
3. Results
Brain-speciﬁc homozygous knockin mice (HOM/+) were gener-
ated by interbreeding heterozygous males, carrying the Nestin-Cre
transgene, with homozygous females (Fig. 1A–D) [17]. Littermate
animals heterozygous for the knockin allele, with and without
Nestin-Cre, (HET/+ and HET/-) were also phenotyped. As reported
previously, homozygous knockin animals exhibited severe micro-
cephaly (Fig. 1C–E) [17] and further showed a reduction in body
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Fig. 1. Tubb5 E401K knockin mice show reduced brain size and body weight. A–C: Schematic of the wild type Tubb5 locus (A) and the conditional E401 K allele, pre and post
Cre-recombination (B and C, respectively). Ex: exon; LoxP: LoxP recombination sites. D: Breeding schematic for the generation of behaviorally assessed mice. Heterozygous
E401  K conditional knockin males carrying a Nestin-Cre transgene were interbred with homozygous knockin females. Heterozygous animals without (HET/-), as well as
heterozygous and homozygous mice with the Nest-Cre transgene (HET/+ and HOM/+, respectively) were used for the described experiments. C-E: Coronal MRI  views of a
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:  Weight quantiﬁcation of animals of the indicated genotypes at 10–12 weeks of
ales;  7 females; sex-matched littermates).
eight (Fig. 1F) (F(2, 39) = 5.275, P = 0.0094; Tukey post-hoc com-
arison: HOM/+ vs. HET/-: P < 0.01; see Table S1 for a summary of all
tatistical analyses in the online version at DOI: http://dx.doi.org/
0.1016/j.bbr.2017.01.029%20). Animals were submitted to a bat-
ery of behavioral tests. In the following order, they were assessed
n: the open ﬁeld; the elevated plus maze; the accelerating rotarod;
tatic rods; and, ﬁnally, for sensorimotor gating. We  tested a total
f 14 littermate trios, which were divided evenly into males (n = 7)
nd females (n = 7). We  did not observe a sex effect for any of the
ehaviors, except for one sound level when assessing the acoustic
tartle response (see Table S2 in the online version at DOI: http://
x.doi.org/10.1016/j.bbr.2017.01.029).
The open ﬁeld test assessed the overall activity of animals, asell as anxiety phenotypes (Fig. 2) [26]. Animals were placed in
 square arena and their movement and position was  tracked for
 min. Homozygous knockin mice, did not show any differences
n the number of entries into or time spent in the open centercrocephaly. Images are derived from the same data set originally presented in [17].
*P < 0.01. Graphs show the individual values as well as the mean ± SEM. n = 14 (7
or their latency center entry (Fig. 2A-B, E). There was a slight,
although non-signiﬁcant increase in distance covered in the open
and peripheral areas during the test, suggesting increased activ-
ity (Fig. 2C–D). Consistent with this result mice spent less time
immobile (Fig. 2F) (number of entries: F(2, 39) = 0.967, adjusted
P > 0.99; open time overall: F(2, 39) = 0.014, adjusted P > 0.99; wall
distance: F(2, 39) = 1.903, adjusted P = 0.97; latency to ﬁrst entry:
F(2, 39) = 0.4119, adjusted P > 0.99; open distance: F(2, 39) = 0.8788,
adjusted P > 0.99).
The elevated plus maze tested anxiety by contrasting behavior in
the open and closed arms of the apparatus (Fig. 3) [26]. In this assay
mice were placed in the middle of an elevated cross-shaped plat-
form with two  walled and to open arms. Movement and position
were then tracked automatically. In general, homozygous knockin
animals exhibited a higher ratio of open to closed arm entries
indicative of decreased anxiety, however, this result was not signiﬁ-
cant (Fig. 3A–D) (entries open/closed ratio: F(2, 39) = 3689, adjusted
50 M.W. Breuss et al. / Behavioural Brain Research 323 (2017) 47–55
Fig. 2. E401K knockin animals do not show behavioral abnormalities in an open ﬁeld test. A-F: Quantiﬁcation of several parameters measured during the open ﬁeld test.
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all  (D), the latency of ﬁrst entry into the open ﬁeld (E), and the time a mouse rem
7  males; 7 females; sex-matched littermates).
 = 0.103). Nor were there signiﬁcant differences when comparing
he ratios of distance covered in the open versus closed arms, time
pent in open versus closed arms, or the total distance travelled
Fig. 3A–D) (distance open/closed ratio: F(2, 39) = 0.7739, adjusted
 > 0.99; time open/closed ratio: F(2, 39) = 0.0865, adjusted P > 0.99;
otal distance covered: F(2, 39) = 0.758, adjusted P > 0.99).
The accelerating rotarod was employed to test balance and
otor coordination (Fig. 4) [26]. In this test, animals were posi-
ioned on a slowly accelerating rod in three separate trials andB), the distance covered by an individual mouse in the open ﬁeld (C) and along the
immobile (F). Graphs show the individual values as well as the mean ± SEM. n = 14
the latency to fall was  recorded. Overall, we did not observe
any signiﬁcant differences when comparing homozygous knockin
mice with their heterozygous and control littermates (Fig. 4) (F(2,
39) = 1.987, P = 0.151). This may  be related to the reduced weight of
homozygous knockin animals (Fig. 1F). We did observe a notice-
able improvement in the performance of control animals over
three trials, that was  not evident in heterozygous or homozygous
mutants (Tukey post-hoc comparison: HET/-; Trial 1 vs Trial 3;
P = 0.001). We  complemented this analysis with an assessment on
M.W. Breuss et al. / Behavioural Brain Research 323 (2017) 47–55 51
Fig. 3. Fear behavior assessed in an elevated plus maze is unaffected by E401K knockin. A-C: Quantiﬁcation of the ratio of open and closed entrances (A), the ratio of distance
covered in the open and closed arms (B), the ratio of time spent in the open and closed arms (C), and the total distance covered (D). Graphs show the individual values as
well  as the mean ± SEM. n = 14 (7 males; 7 females; sex-matched littermates).
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here  is no signiﬁcant differences between genotypes, HET/- animals show an impr
raphs show mean ± SEM. n = 14 (7 males; 7 females; sex-matched littermates).
he multiple static rods (Fig. 5) [26]. Here, mice were placed on
ve rods with decreasing diameter facing away from a safe plat-
orm. For each rod the time to orient towards the target, and the
otal time taken to reach the target were recorded. This setup
evealed a signiﬁcant difference when comparing genotypes (ori-
ntation time: F(2, 39) = 11.21, adjusted P = 0.0002; target time:
(2, 39) = 10.96, adjusted P = 0.0004; Tukey post-hoc comparison:
rientation time: HOM/+ vs. HET/+: adjusted P = 0.004, HOM/+ vs.
ET/-: adjusted P = 0.0004; target time: HOM/+ vs. HET/+: adjusted
 = 0.006, HOM/+ vs. HET/-: adjusted P = 0.0004). Both, orientationall of the rotarod for the individual animals in three replicate trials. While overall
nt in trial performance that is not evident in HET/+ and HOM/+ animals. **P < 0.01.
(Fig. 5A) and target time (Fig. 5B), were signiﬁcantly longer in the
homozygous knockin animals in comparison to their heterozygous
and control littermates. Heterozygous animals did, in general take
longer to orient and reach the target than controls, however this
was not signiﬁcantly different (orientation time: HET/+ vs. HET/-:
adjusted P > 0.99; target time: HET/+ v HET/-: adjusted P > 0.99).
Most strikingly, mutant animals did not exhibit any improved per-
formance in orientation time following exposure to the setup on
the ﬁrst rod.
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Finally, we tested the acoustic startle response to assess sensori-
otor gating (Fig. 6A) and prepulse inhibition which relates to the
ltering of information and is considered to be an endophenotype
or schizophrenia (Fig. 6B) [28,29]. Analysis of the startle response
o 90 dB, 100 dB, 110 dB, and 120 dB revealed no signiﬁcant differ-
nce between genotypes (Fig. 6A) (90 dB: F(2,36) = 0.967, P > 0.99;
00 dB: F(2,36) = 0.409, P > 0.99; 110 dB: F(2,36) = 0.572, P > 0.99;
20 dB: F(2,36) = 0.563, P > 0.99). We  did observe a sex effect for
10 dB (F (1,36) = 8.03, P < 0.05), but no interaction between sex
nd genotype (F (2,36) = 0.166, P > 0.99). Analysis of prepulse inhi-
ition when presented with a 90 dB and 95 dB prepulse to a 120 dB
timulus revealed a signiﬁcant impairment in HOM/+ animals
Fig. 6B) (F(2, 39) = 3.797, P = 0.03; Tukey post-hoc comparison:
0dB–120 dB: HOM/+ vs. HET/-: P = 0.01).
. Discussion
While behavioral characterization of mouse models of autism
pectrum disorders and schizophrenia have been frequent, only a
ew mouse models with structural brain phenotypes have under-
one behavioral assessment [30–34]. Although a number of mouse
odels for primary microcephaly exist (e.g. Mcph1,  Cdk5rap2,
dr62, and Aspm), to our knowledge none of these animals have
ot been subject to behavioral assessment [18–21]. A mouse model
or Glut-1 deﬁciency syndrome, a disease characterised by seizures,
cquired microcephaly and low glucose levels in the cerebrospinal
uid has been investigated [35]. It has been reported that Glut-1
nockout animals exhibit impaired motor performance, falling
rom the rotarod more frequently accompanied by defects in beam
alking. Similarly, we observed a severe defect in our E401K-B: Quantiﬁcations for orientation (A) and target time (B) needed for the rods of
 ± SEM. n = 14 (7 males; 7 females; sex-matched littermates).
mutant animals when assessing their motor co-ordination on the
static rods apparatus. One of the most striking phenotypes observed
in TUBB5 patients is their delay in motor development and coordi-
nation [5,8]. This phenotype, which is often described in patients
with tubulin gene mutations, may  be associated with basal gan-
glia abnormalities and hypoplasia of the cerebellum [5,8,12,36–38].
Reﬂecting this, the E401 K knockin mice present with a volumetric
reduction in both brain regions [17].
Surprisingly, we also observed defects in sensorimotor gat-
ing, speciﬁcally in prepulse inhibition, impairments of which have
been described in mouse models of schizophrenia [39,40]. For
instance, an ENU-induced mouse model for the schizophrenia gene
Disc1 shows a robust defect in this assay [41,42]. Likewise, var-
ious mutants interfering with NMDA receptor function impair
prepulse inhibition [41]. Although the interpretation of such phe-
notypes can be difﬁcult, dysregulation of TUBB5 expression has
been correlated with schizophrenia previously [43,44]. Moreover,
brain size decrease in general has been associated with this dis-
order [45]. Given these connections, it would be interesting to
test whether drugs that improve prepulse inhibition phenotypes
in schizophrenia mouse models could evoke the same response
in the E401K knockin mice [46]. It is interesting to note that the
Jenna mice, which harbor a S140G mutation in Tuba1a exhibit a
marked increase in locomotor activity and an exaggerated acoustic
startle response which we  did not observe in our E401K animals
[11,28]. This result suggests that different neuronal circuits are
likely perturbed in these mouse lines, perhaps reﬂecting the func-
tional properties or expression patterns of these different tubulin
isoforms.
M.W. Breuss et al. / Behavioural Brain Research 323 (2017) 47–55 53
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It is known that structural brain abnormalities, such as micro-
ephaly, originate from defects in basic biological processes in utero.
he extent to which defects in postnatal neuronal function con-
ributes to a patient’s phenotype is often difﬁcult to ascertain. Given
hat TUBB5 is expressed at moderate levels directly after birth and in
he adult brain, it is conceivable that dysfunction postnatally might
xacerbate any anatomical or behavioral deﬁcits. Consequently,
here is a window in which it might be possible to intervene with
ome therapeutic beneﬁt. For instance, it has been demonstrated
hat postnatal expression of Dcx in a rat model for subcortical band
eterotopia can rescue the phenotype [47]. Similarly, Novarino and
olleagues have described a metabolically induced autism disor-
er, for which treatment in adult mice can improve the behavioral
efects [22]. Postnatal interventions are also being explored for the
reatment of human patients with neuroﬁbromatosis type I and
uberous sclerosis [24,25].
Might a similar approach be successful with respect to TUBB5?
ight we be able to alleviate the disease state by application of a
rug that limits apoptotic cell death, or alternatively drive expres-
ion of another, closely related tubulin isoform? Drugs with the
otential to inhibit apoptosis are of great interest for neurodegen-
rative disorders or treatment of acute cell death due to insult,
uch as stroke induced hypoxia [48]. Although inhibition of the
poptotic cascade is possible, alternative pathways often ensure
hat cell death is only delayed rather than prevented. A recent
tudy by Jiang and colleagues, however, reports the discovery of a
mall molecule that protects the integrity of the electron transport
hain in mitochondria, limiting apoptosis [49]. Preliminary tests in
 mouse model of neurodegeneration were promising and make ite inhibition. A: Quantiﬁcation of the weight-normalized startle response for the
ponse to a 120 dB sound following a prepulse of the indicated intensity. *P < 0.05.
a viable compound to test in mouse models of microcephaly that
are driven by apoptotic cell death.
The extent to which different tubulin isoforms are functional
redundant is not clear, however, it may  also be beneﬁcial to induce
overexpression of another tubulin isoform postnatally (e.g. TUBB2A
or TUBB2B) [50]. In instances where heterozygous TUBB5 muta-
tions act by loss of function compounds that increase expression of
TUBB5 itself may  also be of utility. The existence of different tubulin
GFP-reporter lines (e.g. Tg(Tubb5-GFP))  could be used to assess the
ability of compounds to upregulate tubulin expression providing
avenues to test these ideas [8,17,50].
5. Conclusions
Taken together, we have described the behavioral characteriza-
tion of the Tubb5 E401K knockin model and discovered defects in
motor control and, unexpectedly, prepulse inhibition of the acous-
tic startle response. Our study provides quantitative behavioral
readouts that could be used to assess the utility of therapeutic
interventions for TUBB5 associated neurological disease.
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